Chitosan mediated solid lipid nanoparticles for enhanced liver delivery of zedoary turmeric oil in vivo.


Journal

International journal of biological macromolecules
ISSN: 1879-0003
Titre abrégé: Int J Biol Macromol
Pays: Netherlands
ID NLM: 7909578

Informations de publication

Date de publication:
15 Apr 2020
Historique:
received: 24 07 2019
revised: 15 01 2020
accepted: 22 01 2020
pubmed: 29 1 2020
medline: 15 12 2020
entrez: 29 1 2020
Statut: ppublish

Résumé

Zedoary turmeric oil (ZTO) has a strong antitumor activity. However, its volatility, insolubility, low bioavailability, and difficulty of medication owing to oily liquid limit its clinical applications. Solid lipid nanoparticles can provide hydrophobic environment to dissolve hydrophobic drug and solidify the oily active composition to decrease the volatility and facilitate the medication. Chitosan has been widely used in pharmaceutics in recent years and coating with chitosan further enhances the internalization of particles by cells due to charge attract. Here, Chitosan (CS)-coated solid lipid nanoparticles (SLN) loaded with ZTO was prepared and characterized using dynamic laser scanner (DLS) and transmission electron microscope (TEM). The uptake and distribution of drug were evaluated in vitro and in vivo. The average sizes of ZTO-SLN and CS-ZTO-SLN were 134.3 ± 3.42 nm and 210.7 ± 4.59 nm, respectively. CS coating inverted the surface charge of particles from -8.93 ± 1.92 mV to +9.12 ± 2.03 mV. The liver accumulation of CS-ZTO-SLN was higher than ZTO-SLN (chitosan-uncoated particles) by analysis of tissue homogenate using HPLC, and the bioavailability of ZTO was also obviously improved. The results suggested that SLN coated with CS improved the features of ZTO formulation and efficiently deliver drug to the liver.

Identifiants

pubmed: 31987952
pii: S0141-8130(19)35753-8
doi: 10.1016/j.ijbiomac.2020.01.222
pii:
doi:

Substances chimiques

Antineoplastic Agents, Phytogenic 0
Drug Carriers 0
Lipids 0
Plant Oils 0
Chitosan 9012-76-4

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

108-115

Informations de copyright

Copyright © 2020. Published by Elsevier B.V.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that there is no conflict of interest regarding the publication of this paper.

Auteurs

Bo Yang (B)

School of Pharmacy, Harbin University of Commerce, 138, Tong Da Street, Harbin 150076, China.

Jiaqi Jiang (J)

Department of Pharmaceutics, Daqing Campus, Harbin Medical University, 1 Xin Yang Road, Daqing 163319, China.

Lei Jiang (L)

Department of Pharmaceutics, Daqing Campus, Harbin Medical University, 1 Xin Yang Road, Daqing 163319, China.

Peiyu Zheng (P)

School of Pharmacy, Harbin University of Commerce, 138, Tong Da Street, Harbin 150076, China.

Fuling Wang (F)

School of Pharmacy, Harbin University of Commerce, 138, Tong Da Street, Harbin 150076, China.

Yang Zhou (Y)

School of Pharmacy, Harbin University of Commerce, 138, Tong Da Street, Harbin 150076, China.

Zhong Chen (Z)

Department of Pharmaceutics, Daqing Campus, Harbin Medical University, 1 Xin Yang Road, Daqing 163319, China.

Minghui Li (M)

Department of Pharmaceutics, Daqing Campus, Harbin Medical University, 1 Xin Yang Road, Daqing 163319, China.

Mingming Lian (M)

Department of Pharmaceutics, Daqing Campus, Harbin Medical University, 1 Xin Yang Road, Daqing 163319, China.

Shukun Tang (S)

Department of Pharmaceutics, Daqing Campus, Harbin Medical University, 1 Xin Yang Road, Daqing 163319, China.

Xiaoying Liu (X)

Department of Pharmaceutics, Daqing Campus, Harbin Medical University, 1 Xin Yang Road, Daqing 163319, China. Electronic address: liuliuaoe@126.com.

Haisheng Peng (H)

Department of Pharmaceutics, Daqing Campus, Harbin Medical University, 1 Xin Yang Road, Daqing 163319, China. Electronic address: fisher1688@163.com.

Qun Wang (Q)

Department of Chemical and Biological Engineering, Iowa State University, Ames, IA 50011, United States. Electronic address: qunwang@iastate.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH